Active Ingredient: MIDOSTAURIN
Proprietary Name: RYDAPT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N207997
Product Number: 001
Approval Date: Apr 28, 2017
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information